UT Southwestern Researcher Selected for ASBMB Merck Award
News Jul 18, 2014
Dr. Zhijian “James” Chen, Professor of Molecular Biology and a Howard Hughes Medical Institute investigator at UT Southwestern Medical Center, has been named the 2015 recipient of the American Society for Biochemistry and Molecular Biology (ASBMB) Merck Award, which recognizes outstanding contributions to research in biochemistry and molecular biology.
Dr. Chen, who holds the George L. MacGregor Distinguished Chair in Biomedical Science, is a pioneer in deciphering the mechanisms of cell signaling, inflammation, and innate immunity - the body’s first, generalized response to infection.
“I am extremely honored that the discoveries from our laboratory are being recognized by our scientific colleagues. I’m grateful for the hard work and dedication of the talented people in the lab and the strong support from UT Southwestern,” said Dr. Chen, who is also a member of the Center for Genetics of Host Defense.
Early in his career, Dr. Chen uncovered a new, unexpected role for ubiquitin, a small protein, showing that it activates proteins important in immune regulation and other essential cellular functions. In subsequent work, he found that the cell’s energy-producing machines, the mitochondria, contribute to the body’s immune response and he identified MAVS, a mitochondrial protein essential for immune defense against many RNA viruses such as influenza, West Nile and hepatitis C. More recently, Dr. Chen discovered a new pathway called the cGAS pathway, which activates the immune system in response to microbial and self DNA.
“We are delighted to see Dr. Chen receive this very special recognition of his enormously important discoveries that have advanced understanding of the fundamental mechanisms of cell response to viral infections,” said Dr. Daniel K. Podolsky, President of UT Southwestern and holder of the Philip O’Bryan Montgomery, Jr., M.D. Distinguished Presidential Chair in Academic Administration and the Doris and Bryan Wildenthal Distinguished Chair in Medical Science.
Dr. Chen will present his award lecture, “Enemy within - immune and autoimmune responses to cytosolic DNA and RNA,” at next year’s annual ASBMB meeting in Boston as part of the honors.
“The Merck Award from the American Society for Biochemistry and Molecular Biology is one of its most coveted prizes. Past winners constitute a ‘who’s who’ in the field of biomedical research,” said Dr. Steven McKnight, Chairman of Biochemistry and holder of the Distinguished Chair in Basic Biomedical Research and The Sam G. Winstead and F. Andrew Bell Distinguished Chair in Biochemistry.
Earlier this year, Dr. Chen was elected to the National Academy of Sciences (NAS), one of the highest honors in American science. UT Southwestern has 21 NAS members on its faculty, placing it among the group of academic medical centers with the most NAS members. In 2012, Dr. Chen received the NAS Award in Molecular Biology.
In May, Dr. Chen was inducted into The Academy of Medicine, Engineering and Science of Texas (TAMEST). In 2007, Dr. Chen received TAMEST’s Edith and Peter O’Donnell Award in Science, and, in 2005, the Robert A. Welch Foundation Norman Hackerman Award in Chemical Research.
Study Reveals How MRSA Infection Compromises Lymphatic FunctionNews
Infections of the skin or other soft tissues with the hard-to-treat MRSA bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. Investigators describe how MRSA infection impairs the ability of lymphatic vessels to pump lymphatic fluid to lymph nodes in mouse models, which may contribute to the frequent recurrences of MRSA infection experienced by patients.
Possible Biomarker to Identify Who Would Benefit from ImmunotherapyNews
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments. In a new study, researchers examined tissue samples from melanoma and ovarian cancer patients treated with immunotherapies and found a link between the percentage of antigen-presenting cells expressing PD-L1 and an objective clinical response to treatment.READ MORE
Fight Against Cancer: Drug Combination Helps Kickstart the Immune SystemNews
Scientists from King's College London have found a way to boost the immune system to help it fight back against cancer.
The breakthrough involves the first ever use of a combination of chemotherapy and a drug being trialled as a treatment for neonatal jaundice, that together help kick start the body's natural defences.